Safety and Immunogenicity of BBV121

Clinical trial NCT04478656 · COMPLETED

Trial details

NCT number: NCT04478656
Sponsor: Bharat Biotech International Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Zika Virus Infection

Start date: 2017-06-03
Primary completion: 2017-11-15
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.